The highly anticipated rematch between Anthony Joshua and Dillian Whyte, scheduled for 12 August at the O2 Arena in London, has been cancelled following “adverse analytical findings” from a random drugs test conducted on Whyte. The Voluntary Anti-Doping Association (VADA) made the announcement, raising concerns about the integrity of the upcoming bout.
Promoter Matchroom expressed its commitment to a thorough investigation in response to the findings, aiming to ascertain the veracity of the test results and the implications they may have on Whyte’s participation in the fight. The situation has cast a cloud of uncertainty over the event, leaving fans disappointed and curious about the future of the matchup.
In a statement, Dillian Whyte expressed shock and devastation at the ruling, vehemently denying any wrongdoing. He stated, “I can confirm without a shadow of doubt that I have not taken the reported substance, in this camp or at any point in my life. I am completely innocent and ask to be given the time to go through the process of proving this without anybody jumping to conclusions or a trial by media.”
This is not the first time Whyte has faced such allegations, having previously been reported for an adverse finding for a substance he claims he did not consume. He remains determined to prove his innocence and clear his name, willing to cooperate fully with the investigation.
The rivalry between Anthony Joshua and Dillian Whyte dates back to their amateur days, with Whyte securing a victory over Joshua before the latter went on to win an Olympic gold medal in 2012. As professionals, they engaged in a British heavyweight title match in 2015, with Joshua emerging as the winner.
The cancellation of the rematch has left boxing enthusiasts disappointed, as the bout promised to be an intense and thrilling contest between two highly skilled fighters. As the investigation unfolds, both fighters’ careers and reputations hang in the balance, and the boxing world awaits further updates from the authorities and promoter Matchroom.